UNH: Knife or Generational Opportunity?News today that NYSE:UNH suspended 2025 guidance and CEO stepped down led to a massive route... right down to the 50% Retracement from the 2008 bottom to the former All Time High.
This is potentially a big opportunity for a long term position at this level: 322. I would have preferred the level to be matched by a Volume Profile level but the nearest one below is at 244. I can still see a good risk adjusted trade back to the median of the down move initially and onward to a full recovery.
I took a moderate position in tax advantaged accounts for the long term hold and will keep an eye on this level for a more tactical setup (a spike or further price action to confirm the hold).
UNH trade ideas
Life Time Opportunity Trade Setup NYSE:UNH
Entry Price: $280 (at market open)
Profit Target: $400
Stop Loss: $250
Risk-Reward Ratio: 4.3:1
Position Size: 1% of portfolio
Why Bullish?
UNH is trading near a 5-year low ($248.88) after a -50% drop in a month, driven by a DOJ Medicare fraud probe and CEO change. Despite the noise, analysts are bullish with 55 Buy ratings and a $445-$460 target, pointing to undervaluation (forward P/E ~10x). Institutional buying (Viking Global +12.5% stake) and a low VIX (17.83) support a potential rebound.
Key Catalysts
Technicals: Near 52-week low, RSI oversold, potential reversal.
Fundamentals: $400B revenue, 15% EPS growth projected long-term.
News: DOJ probe and suspended 2025 guidance weigh, but analysts see overreaction.
Macro: VIX at 17.83 (stable), 10-year yields at 4.424% (headwind).
Risks
Ongoing DOJ investigation could escalate.
Rising medical costs and volatile sentiment.
Further downside if support at $250 breaks.
Chart Notes
UNH testing major support at $250-$270.
Volume spikes on selling, but capitulation may signal a bottom.
Watch for a break above $300 to confirm bullish momentum.
Keep your long term vision
Follow for the Best AI generated Signals on the market
Ash.
This will not be a V-Shape recoverySignificant headwinds await UNH. From an institutional investment perspective, these are not the market conditions when you pile on risk holding onto this stock. Firms will de-risk and UNH clearly has been chopped!! Be cautions…UNH will be highly volatile and is extremely risky!!
5/15/25 - $unh - I'll comment.5/15/25 :: VROCKSTAR :: NYSE:UNH
I'll comment.
- as a rule, i typically avoid companies that have credible issues associated with frauds. we all know UNH committed some pretty heinous crimes against humanity
- institutions that want to buy this thing at $250 are probably getting massive pushback from their risk teams today and being told "fine don't sell as much" (even tho they r going to be forced to trim), but no add.
- so any bid here comes from a headline (real or fake). add to this you have 5/16 opex tmr, this ticker isn't an insignificant mcap and so index and flows work against it at the mgn. furthermore, any statement forthcoming perhaps doesn't hit until next week? i mean... the mgmt team is running or getting *squashed*. lawyers r not going to push for immediate statements here bc *muh stock price*
- options chain pretty solid around $250. stock probably doesn't have a ton left to go here.
- IFFFFFF i were to trade this long, i'd probably wait for an abysmal close. and a red open. and i'd punt on some call spreads next week. let's see. but given NXT and GAMB today that r keeping me busy... i have zero interest to complicate my life.
idk if that helps but i've gotten a lot of DMs
oh on valuation... there's no "E" we can stand on here. so realistically this could easily trade at single digit PE on re-rated expectations which is another 25% lower... keep that in mind. this won't be a V shaped recovery trade. so timing/ and paying VERY close attention is what's required to get an edge/ make risk-adj. $. just not my cup of tea.
oh - and F the crooks here. we all know u r guilty.
V
UNH | Catching the Fall Risky Play💊 Oversold Swing Play
⚠️ Risk Factor
You're not trading a bounce—you’re stepping into a fire. Legal risk + uncertainty = extreme volatility. However, if markets stabilize, UNH could deliver a powerful mean-reversion move.
UnitedHealth ( NYSE:UNH ) is trading in panic territory after:
DOJ launched a criminal probe tied to Medicare Advantage billing
Abrupt CEO resignation
Suspended 2025 financial guidance, sparking investor selloff
Still, the fundamentals aren’t dead. Q1 revenue is strong, and long-term value is on the table.
🎯 Trade Plan
🟢 Entry Zones
🔹 Zone 1: $275–$285 → Technical support + RSI oversold
🔹 Zone 2: $255 → 2021 breakout retest
🔹 Zone 3: $225 → Ultimate fear zone (deep capitulation possible)
💰 Profit Targets
✅ TP1: $300 – Psychological level & minor resistance
✅ TP2: $340 – Gap-fill area & 50-day MA
✅ TP3: $385+ – Long-term value zone if sentiment reverses
📌 Final Word
UNH is no penny stock—it’s a $280B giant under siege. If you believe fear is overdone, this is a calculated shot at a rebound. Just keep your stops tight and your thesis tighter.
🚨 Disclaimer: This is not financial advice. Trading involves risk. Always DYOR and manage your exposure carefully.
UNH is a Great Opportunity Following Panic Sell-Off UNH remains a solid business with a great potential upside. The recent drop was driven by softer financials, CEO resignation, and a DOJ probe—more fear than fundamentals.
Core operations are stable. Valuation is now attractive, making this a solid entry point for patient investors.
Many argue that UNH is just an insurance business, not a tech company. They are wrong. UNH holds a massive amount of healthcare data that can be leveraged for insights, efficiency, and innovation. This data is not just an asset—it is a moat that few competitors can replicate.
The recent insider buying is a green flag ! a signal for investors that there are no skelatons in the closet
On the chart, increasing green volume supports bullish sentiment. The 10-day EMA has crossed above the 20-day EMA on the hourly timeframe, indicating short-term upward momentum. Additionally, the MACD is turning positive indicating less fear and more greed!, and RSI is trending higher—both pointing to strengthening buying pressure.
What price action says about UNHThe recent +55% drop in UNH represents a major breakdown from its long-term price structure. Historically, recoveries in this stock have been slow and gradual rather than sharp rebounds. There is a critical support zone between $190 and $155. While the damage to the stock is significant, this support zone provides a logical area where a patient, steady recovery could develop over time.
- UNH Down 38.2%—Are Buyers Ready to Step In?- "Healthcare Stocks at Higher Timeframe Support (Golden Ratio) —Bounce Incoming?"
Key Reasons for UNH’s Stock Decline
✅ CEO Resignation → Andrew Witty stepped down for personal reasons, and former CEO Stephen Hemsley returned to stabilize the company.
✅ Suspended 2025 Outlook → UNH withdrew its financial guidance, citing higher-than-expected medical costs from new Medicare Advantage members.
✅ Regulatory Scrutiny → The DOJ is investigating UNH for possible Medicare fraud, adding uncertainty.
✅ Cybersecurity Breach → A massive data breach at its subsidiary Change Healthcare affected 190 million records, disrupting operations.
✅ Stock Market Reaction → UNH shares plummeted 16% in a single day, marking their lowest level in nearly five years.
🔹 Future Outlook
Despite setbacks, UNH remains a dominant player in healthcare, with over 50 million insured members. Analysts believe the company can recover under Hemsley’s leadership, but short-term volatility remains high.
United Health Group (UNH) trading at 250$ 0.618 F5 Support ( Golden Ratio )
Anticipating buyers to come in at this level.
XLV. The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund (ETF) that tracks the healthcare sector within the S&P 500. It includes companies from pharmaceuticals, biotechnology, healthcare equipment, and healthcare services.
This sector is trading near Weekly Support Nodes
Weekly OP + Weekly F3 nodes
or Weekly OP F3 Agreement
Its also Oversold.
ELV - Elevance Health Inc, one of the main competitors to UNH in this space
trading at Weekly F3 Support ( 0.382 retracement ) + Weekly Oversold
Given UNH, ELV and the broader sector, XLV, are all trading at important Higher Timeframe Support nodes...
with UNH down 20% today at one point, and down 38.2% from its highs ( largely within a month )
Looking for a Technical Bounce against Higher Timeframe Support nodes, on UNH, and the sector.
"Will we see a bounce at these levels? Drop your thoughts below!"
- Joseph AuXano
#UNH #XLV #HealthcareStocks #TradingView
UNH and DOJ. What has ever happened? Value stock Back with another freebie for the followers. I am not getting enough love after the freebies and multibaggers I have thrown at the community.
UNH. Investigations, fraud, malpractices.
Does that change the fact that it is the biggest health insurer in the USA? People reading this might be insured with UNH.
What have investigations ever brought the USA?
A slap on the wrist, a fine and some low key employee fired. Does that change your insurance? Does that wipe out 100+ billion from UNH balance sheet? NO
A value stock for a value investor.
The Foxx announces a position of 10000 stocks of UNH @284.1 post market 19:35 on May 14 2025. Happy to average down till it goes to 1. That is conviction. Bill ackman who?
Follow the Foxx, throw some love in the comments, and ill maybe throw another bone for yall soon..
$UNH: With stock down more than 60%, is it in buy zone? NYSE:UNH with one after bad news lost 60% of its market cap from its ATH of 600$. NYSE:UNH the largest insurer in US has been in news for all the wrong reasons. The stock after losing 60% of the value has a dividend yield of 3.1% which is 2.5 times of the S&P Yield. The historical dividend growth of NYSE:UNH has been more than 8%. This makes NYSE:UNH a compelling story stock during the recent downturn. With recent insider buys of the NYSE:UNH stock most of the fundamental indicators indicate a positive outlook.
But what are the technical indicators telling us? Today we are looking at the historical chart of the stock. The last time the stock was down more than 60% was during the 2007-2008 Financial recession. In 2008 it did lose more than 64%. If we investigate the long term RSI then we see it below 25 which we also saw last during the Financial recession.
Verdict : Buy 1/3 @ 250, Buy 1/3 @ 275, Buy 1/3 now.
UnitedHealth Group | UNH | Long at $323.00UnitedHealth Group NYSE:UNH currently has a P/E near 15x, steady rising revenue (2024 = $400+ billion), EPS of 6.24x, dividend of 2.2%, and earnings are forecast to grow by 10.8% per year. The stock, however, has plummeted recently due to negative news, rising healthcare costs, CEO changes, and suspension of 2025 outlook. Every company has bumps, but I view solid companies like NYSE:UNH as pure opportunities for long-term investment - especially with America's aging population.
From a technical analysis perspective, the stock price has entered my "crash" simple moving average zone (which currently extends down near $307.00). Personally, this is the zone I am starting a position due to the odds of a future bounce from here. However, I am very aware that there is an open price gap near $265.00 that may get filled this year or early next. I could see a bounce in my crash zone to bring in the bulls and then a drop to that level to heighten the fear. That is another area I plan to grab more shares and build a strong position. But, in case it doesn't extend that low, I have started a position at $223.00, with future investments near $307.00 and below. I doubt this will be a quick turnaround stock - patience is where money is made.
Targets (into 2028):
$375.00
$475.00
$580.00
UnitedHealth UNH - Institutional Exit or Long-Term Opportunity?Key Insights
UNH has witnessed a historic -24% monthly drop, breaking multiple key long-term supports on extreme volume — often a sign of institutional distribution or capitulation.
Bearish Outlook (Primary Bias):
Current price is testing the 0.5 Fibonacci retracement ($322 - $287), a critical make-or-break zone.
A monthly close below $287 will likely trigger the next leg lower toward $250 and possibly the $200 psychological handle.
The bearish momentum remains dominant, confirmed by RSI deep in bear territory and MACD accelerating down.
Invalidation Levels (For Shorts):
Aggressive short invalidation: Weekly close above $395.33.
Full bearish invalidation (shift to bullish bias): Monthly close above $447.21.
Bullish Opportunity Zones:
Watch for strong bullish reversal at the $287 - $249 support zone, aligning with 0.382 Fib and historical demand.
If $200 - $160 is ever reached, it becomes a high-probability accumulation zone for long-term investors.
Probability:
$395 - $447 Strong Short Bias , Look for retests & rejection
$322 - $287 Neutral to Bearish (watch reaction), Currently testing key support
$249 - $200 High-Probability Long Setup, Look for confirmation reversal
Above $447.21 Bullish Bias Resumes, Invalidate bears, shift to longs
Conclusion:
UNH is at a critical long-term support crossroad.
Patience is key—traders should avoid chasing the lows and wait for higher-probability setups at key levels.
Let the chart guide the trade
UnitedHealth: Reversal incoming?UnitedHealth: The UNH stock is undergoing a correction phase, with the possibility of further declines into the - support zone. This level is marked as a strong long-term buy opportunity for investors, and price recovery is expected from this zone. Should this correction unfold as anticipated, the stock could rally to and beyond, with potential targets at and in the longer term.
Thank you for taking the time to read my analysis.
I look forward to reading your thoughts.
Best regards,
Mattner
UNH can retrace the fib and come back to the lowSee trading is all about risk and probability.
There is news flowing left and right about insiders buying UNH for the dip, a director bought about $1m single handedly.
But remember, DOJ is serious about the Medicare Fraud Probe.
I believe since there is a huge, huge downfall from April 16, 2025... there will definitely be a retracement, but not till .5 or .618, imo.
So after retracement to 381 range, it may again fall down to 250 low ( as rapid downfall, suggests retracement to only 0.38 range, from my personal experience).
Huge Volume spike is also seen stating a lot of people are being involved in this stock. Some may try to get rid off it as soon as possible, some might speculate the comeback of UNH to 594 normal range.
UNH next strong Support $286As of May 13, 2025, UnitedHealth Group (UNH) stock is experiencing significant volatility due to recent corporate developments:
📉 Current Stock Performance
Price: Around $337.02 in premarket trading, down approximately 11% 1.
Previous Close: $380.72 2.
📰 Key News
CEO Change: Andrew Witty has resigned as CEO for personal reasons. Stephen Hemsley, former CEO (2006–2017), has returned to the role.
2025 Guidance Suspended: UnitedHealth has suspended its 2025 financial outlook due to higher-than-expected Medicare Advantage costs and increased care activity 1.
📊 Analyst Outlook
Consensus Rating: Moderate Buy based on 24 analyst ratings.
Average Price Target: $596.86, suggesting a potential 56.77% upside from the previous close 2.
Price Target Range: $490 to $700.
Would you like a chart of UNH’s recent stock performance or a breakdown of analyst ratings over time?
UNH....OVERSOLD......REVERSAL SOON?UNH testing third support touch at ~$394, with RSI near 30 on the weekly, signaling potential oversold conditions. Despite a tough Q1 with 4% EPS growth and rising medical costs, UNH boasts 10% revenue growth, a 2.08% dividend yield, and a massive 51M member base. Is this a dip to buy?
Where does the tumble stop for $UNHUNH has been in a free fall been absolute chaos for..reasons.
I see a possible Shark. Sharks can complete at the 886 or the 113. This happens to be around the 236 and 382 of the Macro fib retracement. We also have the 200 Monthly SMA.
So where does it stop tumbling? The 236, the 382 or the 200 Monthly SMA? I am betting it goes to the 236 and bounces sometime around earnings. Notice that trendline that goes back to 1998 that acts as support. I am betting it bounces around where the trendline and 236 intersect sometime around the next earnings. That's a good spot to go long.
Now what do you do with UNH ?For me, it is a screaming buy. Hear me out.
This was in my watch list for a while but I never get a chance to go long as the price keeps climbing up or my funds were tied up with other shares/ETFs, etc.
A 50% fall from the peak but what is more important is the parabolic move down, almost 5 straight weeks of 90 degrees plunge down. The sell down seems pretty serious and by any metric you used, it is way oversold and begs for a reversal.
However, on the daily chart, it is still RED which means the selling is not done yet and we could probably see more sell down days ahead to 196-279 price level.
So, I will be watching it closely this time and be ready to nibble some when it falls further.
Healthcare stocks seem to be battered in this sector rotation round so get ready your ammunition , the reversal could come sooner than later........
Cash printing machine on saleFor all the hatred UNH gets, this company is looking like a buy after this huge sell off. We are approaching the golden ratio around $380. The company generates $100bn in revenue per quarter, hence why it’s a highly regarded cash printing machine.
The bearishness may continue as we sit below the 200week MA. I have a worst case scenario of $300 where we have a strong weekly level of support. I think we’ll bottom closer to the mid $300s so I’ll be taking a nibble with a longer term view on this stock.
Not financial advice
Potential buying opportunity on UNH!OptionsMastery:
🔉Sound on!🔉
📣Make sure to watch fullscreen!📣
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!